D B Radner. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralDrug InteractionsDrug Resistance, MicrobialHumansIsoniazid/therapeutic useMycobacterium tuberculosis/drug effectsRifampin/administration & dosageRifampin/adverse effectsRifampin/bloodRifampin/metabolismRifampin/pharmacologyRifampin/therapeutic useTime FactorsTuberculosis/drug therapy
Substances: See more » IsoniazidRifampin
Year: 1973 PMID: 4199024 DOI: 10.1378/chest.64.2.213
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410